Helmholtz Diabetes Center

Institute of Translational Stem Cell Research

The Institute of Translational Stem Cell Research (ITS) aims to develop a new advanced cell therapy to carry out clinical studies in type 1 diabetes patients.

The Institute of Translational Stem Cell Research (ITS) aims to develop a new advanced cell therapy to carry out clinical studies in type 1 diabetes patients.

3D illustration of a pancreatic organoid

About our Research

Research Concept

Basic science forms the foundations of most, if not all medical breakthroughs. To appreciate what goes awry in disease, we must fully understand how cells function in periods of homeostasis. In many epithelial organs, including the pancreas, tissue morphogenesis is inextricably tied to cell fate decisions. In our lab, we aim to understand the connection between epithelial architecture and the commitment of pancreatic progenitor cells to mature endocrine cells. We believe that to understand this process in a physiologically relevant manner, we must integrate findings from mouse and human pancreatic epithelia. Discoveries from our research are incredibly important for improving differentiation protocols that aim to provide functional, glucose-responsive beta cells for use in diabetes cellular therapies.

Read more about ITS

Our News

Icon, Center Template, Diabetes, Featured Publication

Featured Publication, Diabetes, ITS,

New Study Reveals Key to How Pancreatic Insulin-Producing Beta Cells Are Formed

A research team led by Prof. Henrik Semb, Director of the Institute of Translational Stem Cell Research at Helmholtz Munich, has gained new insights into how immature pancreatic cells decide whether to become insulin-producing beta cells or…

Semb Lab Behind the Scenes

Diabetes, ITS, IDR,

Handcrafted Langerhans Islets: New Hope for Type 1 Diabetes Patients?

Our organs do a remarkable job day in and day out, without ourselves even having to think about it. Our body has its own ventilation system, a clearance system for toxins, and a system to balance energy homeostasis. But what if one of these systems…

Awards & Grants, ITS,

EU-Project ISLET: Helmholtz Munich takes over coordination

The EU-funded ISLET project brings together leading experts in the field of stem cell research to discover a new advanced cell therapy in type 1 diabetes. The aim is to free patients from the daily use of an insulin pump by replacing the damaged…

csm_INS_Red_PDX1_White_DAPI_Blue_1__a5905e7ee4

New Research Findings, ITS,

Trigger in MODY3 diabetes: Insulin hypersecretion precedes pancreatic β cell failure

In order to treat patients with diabetes in the best possible way it is necessary to understand the disease mechanism. MODY type 3 (MODY3) is a monogenic hereditary form of diabetes, that is caused by a genetic defect in the HNF1A gene. The result is…

Scientists at ITS

freigestelltes Porträtbild für Kontakte auf der Website
Prof. Dr. Tor Henrik Semb

Director, Institute of Translational Stem Cell Research, ITS

View profile
Dr. Minodora Brimpari

Scientific Project Manager

Dr. Chenglei Tian

Postdoc

Dr. Ivan Kulik

Postdoc

Carla Méndez Muñoz

TA-BTA, ITS

Maria Scamozzi

TA-BTA, ITS

Sci. China Life Sci., 14 (2026)

Heng, D. ; Jin, K. ; Yin, G. ; Tian, C. ; Sheng, X. ; Lu, J. ; Wu, Y. ; Ye, X. ; Shi, P. ; Li, H. ; Liu, C. ; Liu, L. ; Zhu, Z.

Reprogramming senescent granulosa cells for germ-cell generation.

Jackson, A.L. ; Heilmann, S. ; Agerskov, R. ; Ebeid, C. ; Krivokapic, J.M. ; Romero Herrera, J.A. ; Semb, H. ; Nyeng, P.

Real-time imaging reveals new mechanisms for pancreatic ductal establishment and remodeling.
J. Pineal Res. 77:e70073 (2025)

Singh, T. ; Kalamajski, S. ; Cunha, J.P.M.C.M. ; Hladkou, S. ; Roberts, F. ; Gheibi, S. ; Soltanian, A. ; Yektay Farahmand, K. ; Ekström, O. ; Mamidi, A. ; Franks, P.W. ; Rosengren, A. ; Semb, H. ; Mulder, H. ; Fex, M.

Modeling genetic risk of β-cell dysfunction in human induced pluripotent stem cells from patients carrying the MTNR1B risk variant.
EMBO Rep., DOI: 10.1038/s44319-025-00610-6 (2025)

Ebeid, C. ; Rump, A. ; Tian, C. ; Mamidi, A. ; de Arcangelis, A. ; Gradwohl, G. ; Semb, H.

Extracellular matrix-driven metabolic control of pancreatic endocrine lineage allocation.
Cell Metab. 37, 1460-1481.e17 (2025)

Chubanava, S. ; Karavaeva, I. ; Ehrlich, A.M. ; Justicia, R.M. ; Basse, A.L. ; Kulik, I. ; Dalbram, E. ; Ahwazi, D. ; Heaselgrave, S.R. ; Trošt, K. ; Stocks, B. ; Hodek, O. ; Rodrigues, R.N. ; Havelund, J.F. ; Schlabs, F.L. ; Larsen, S. ; Yonamine, C.Y. ; Henriquez-Olguin, C. ; Giustarini, D. ; Rossi, R. ; Gerhart-Hines, Z. ; Moritz, T. ; Zierath, J.R. ; Sakamoto, K. ; Jensen, T.E. ; Færgeman, N.J. ; Lavery, G.G. ; Deshmukh, A.S. ; Treebak, J.T.

NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging.
Dev. Cell 60, 1871-1883.e5 (2025)

Tiemann, U. ; Tian, C. ; Hermann, F. ; Proks, M. ; Skovgaard, E. ; Kulik, I. ; Di, Y. ; Sedzinski, J. ; Semb, H.

Pancreatic alpha and beta cell fate choice is directed by apical-basal polarity dynamics.
Diabetologia 67, 1066-1078 (2024)

Villalba, A. ; Gitton, Y. ; Inoue, M. ; Aiello, V. ; Blain, R. ; Toupin, M. ; Mazaud-Guittot, S. ; Rachdi, L. ; Semb, H. ; Chedotal, A. ; Scharfmann, R.

A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation.
Cell Stem Cell 30, 38-51.e8 (2023)

Hermann, F.M. ; Kjærgaard, M.F. ; Tian, C. ; Tiemann, U. ; Jackson, A. ; Olsen, L.R. ; Kraft, M. ; Carlsson, P.O. ; Elfving, I.M. ; Kettunen, J.L.T. ; Tuomi, T. ; Novak, I. ; Semb, H.

An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells.
Dev. Cell 49, 31-47.e9 (2019)

Nyeng, P. ; Heilmann, S. ; Löf-Öhlin, Z.M. ; Pettersson, N.F. ; Hermann, F.M. ; Reynolds, A.B. ; Semb, H.

P120ctn-mediated organ patterning precedes and determines pancreatic progenitor fate.
Nature 564, 114-118 (2018)

Mamidi, A. ; Prawiro, C. ; Seymour, P.A. ; de Lichtenberg, K.H. ; Jackson, A. ; Serup, P. ; Semb, H.

Mechanosignalling via integrins directs fate decisions of pancreatic progenitors.
Nat. Cell Biol. 19, 1313-1325 (2017)

Löf-Öhlin, Z.M. ; Nyeng, P. ; Bechard, M.E. ; Hess, K. ; Bankaitis, E. ; Greiner, T.U. ; Ameri, J. ; Wright, C.V. ; Semb, H.

EGFR signalling controls cellular fate and pancreatic organogenesis by regulating apicobasal polarity.
Cell Rep. 19, 36-49 (2017)

Ameri, J. ; Borup, R. ; Prawiro, C. ; Ramond, C. ; Schachter, K.A. ; Scharfmann, R. ; Semb, H.

Efficient generation of glucose-responsive beta cells from isolated GP2+ human pancreatic progenitors.
Cell Stem Cell 16, 639-652 (2015)

Funa, N.S. ; Schachter, K.A. ; Lerdrup, M. ; Ekberg, J. ; Hess, K. ; Dietrich, N. ; Honoré, C. ; Hansen, K. ; Semb, H.

β-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4.

Kesavan, G. ; Lieven, O. ; Mamidi, A. ; Öhlin, Z.L. ; Johansson, J.K. ; Li, W.C. ; Lommel, S. ; Greiner, T.U. ; Semb, H.

Cdc42/N-WASP signaling links actin dynamics to pancreatic β cell delamination and differentiation.
Dev. Biol. 352, 267-277 (2011)

Sand, F.W. ; Hörnblad, A. ; Johansson, J.K. ; Lorén, C. ; Edsbagge, J. ; Ståhlberg, A. ; Magenheim, J. ; Ilovich, O. ; Mishani, E. ; Dor, Y. ; Ahlgren, U. ; Semb, H.

Growth-limiting role of endothelial cells in endoderm development.
PLoS ONE 5:e12533 (2010)

Fischer, Y. ; Ganic, E. ; Ameri, J. ; Xian, X. ; Johannesson, M. ; Semb, H.

NANOG reporter cell lines generated by gene targeting in human embryonic stem cells.
Stem Cells 28, 45-56 (2010)

Ameri, J. ; Ståhlberg, A. ; Pedersen, J. ; Johansson, J.K. ; Johannesson, M.M. ; Artner, I. ; Semb, H.

FGF2 specifies hESC-derived definitive endoderm into foregut/midgut cell lineages in a concentration-dependent manner.
Cell 139, 791-801 (2009)

Kesavan, G. ; Sand, F.W. ; Greiner, T.U. ; Johansson, J.K. ; Kobberup, S. ; Wu, X. ; Brakebusch, C. ; Semb, H.

Cdc42-mediated tubulogenesis controls cell specification.

Selected Publications

Sci. China Life Sci., 14 (2026)

Heng, D. ; Jin, K. ; Yin, G. ; Tian, C. ; Sheng, X. ; Lu, J. ; Wu, Y. ; Ye, X. ; Shi, P. ; Li, H. ; Liu, C. ; Liu, L. ; Zhu, Z.

Reprogramming senescent granulosa cells for germ-cell generation.

Jackson, A.L. ; Heilmann, S. ; Agerskov, R. ; Ebeid, C. ; Krivokapic, J.M. ; Romero Herrera, J.A. ; Semb, H. ; Nyeng, P.

Real-time imaging reveals new mechanisms for pancreatic ductal establishment and remodeling.
J. Pineal Res. 77:e70073 (2025)

Singh, T. ; Kalamajski, S. ; Cunha, J.P.M.C.M. ; Hladkou, S. ; Roberts, F. ; Gheibi, S. ; Soltanian, A. ; Yektay Farahmand, K. ; Ekström, O. ; Mamidi, A. ; Franks, P.W. ; Rosengren, A. ; Semb, H. ; Mulder, H. ; Fex, M.

Modeling genetic risk of β-cell dysfunction in human induced pluripotent stem cells from patients carrying the MTNR1B risk variant.
EMBO Rep., DOI: 10.1038/s44319-025-00610-6 (2025)

Ebeid, C. ; Rump, A. ; Tian, C. ; Mamidi, A. ; de Arcangelis, A. ; Gradwohl, G. ; Semb, H.

Extracellular matrix-driven metabolic control of pancreatic endocrine lineage allocation.
Cell Metab. 37, 1460-1481.e17 (2025)

Chubanava, S. ; Karavaeva, I. ; Ehrlich, A.M. ; Justicia, R.M. ; Basse, A.L. ; Kulik, I. ; Dalbram, E. ; Ahwazi, D. ; Heaselgrave, S.R. ; Trošt, K. ; Stocks, B. ; Hodek, O. ; Rodrigues, R.N. ; Havelund, J.F. ; Schlabs, F.L. ; Larsen, S. ; Yonamine, C.Y. ; Henriquez-Olguin, C. ; Giustarini, D. ; Rossi, R. ; Gerhart-Hines, Z. ; Moritz, T. ; Zierath, J.R. ; Sakamoto, K. ; Jensen, T.E. ; Færgeman, N.J. ; Lavery, G.G. ; Deshmukh, A.S. ; Treebak, J.T.

NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging.
Dev. Cell 60, 1871-1883.e5 (2025)

Tiemann, U. ; Tian, C. ; Hermann, F. ; Proks, M. ; Skovgaard, E. ; Kulik, I. ; Di, Y. ; Sedzinski, J. ; Semb, H.

Pancreatic alpha and beta cell fate choice is directed by apical-basal polarity dynamics.
Diabetologia 67, 1066-1078 (2024)

Villalba, A. ; Gitton, Y. ; Inoue, M. ; Aiello, V. ; Blain, R. ; Toupin, M. ; Mazaud-Guittot, S. ; Rachdi, L. ; Semb, H. ; Chedotal, A. ; Scharfmann, R.

A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation.

Networks and Affiliations

EU ISLET LOGO

ISLET Project

Read more

Contact

freigestelltes Porträtbild für Kontakte auf der Website
Prof. Dr. Tor Henrik Semb

Director, Institute of Translational Stem Cell Research, ITS

Building / Room: 3620, 4b

View profile

Looking for a new challenge?

Join our team.